Trial Profile
Effect of rosuvastatin on ventricular remodelling cytokines and neurohormones in patients with chronic heart failure.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2011
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Chronic heart failure
- Focus Pharmacodynamics
- Acronyms UNIVERSE
- 03 Feb 2011 Substudy results published in the International Journal of Cardiology.
- 05 Nov 2010 New trial record.